Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Medical - Pharmaceuticals

Healthcare
$13.31 +5.43%

+$0.76 today

Market cap
$800.64M
Beta
0.00
52W Low $13.50High $25.93

Volume 0.21M

Average 0.38M

LTGO Total Assets

Everything the company owns or controls; equal to total liabilities plus equity.

No reported Total Assets figures are available to summarize.

Total Assets history

Currency unavailable · from the balance sheet

No Total Assets data reported for this period type.

Total Assets vs competitors

How LTGO compares with its peers on the latest reported figures

LTGO Competitors
Total Assets for LTGO and competitors
Company Period Latest balance YoY 3-year CAGR
COLLCollegium Pharmaceutical, Inc.Mar 2026$1.65B USD+1.3%+12.2%
PCRXPacira BioSciences, Inc.Mar 2026$1.21B USD-23.8%-9.0%
SCLXScilex Holding CompanyMar 2026$293.64M USD+271.8%+61.6%
LTGOLatigo Biotherapeutics Inc.—— ——
Peer median (excluding LTGO) —+1.3%+12.2%

Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Intrinsic Alpha fair value

Locked

Current Price

$13.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.